Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target. (Q37815604)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target.	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21129604

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21129604%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 January 2020

review article

1 reference

stated in

Europe PubMed Central

title

Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21129604

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21129604%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 January 2020

author

Fortunato Ciardiello

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21129604

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21129604%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 January 2020

Michele Orditura

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21129604

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21129604%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 January 2020

author name string

F De Vita

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21129604

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21129604%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 January 2020

F Giuliani

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21129604

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21129604%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 January 2020

N Silvestris

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21129604

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21129604%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 January 2020

G Catalano

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21129604

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21129604%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 January 2020

publication date

1 November 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21129604

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21129604%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 January 2020

published in

Cancer Treatment Reviews

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21129604

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21129604%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 January 2020

volume

36 Suppl 3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21129604

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21129604%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 January 2020

page(s)

S11-5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21129604

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21129604%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 January 2020

cites work

The epidemiology of gastric cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0305-7372%2810%2970014-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

An evidence-based medicine review of lymphadenectomy extent for gastric cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0305-7372%2810%2970014-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0305-7372%2810%2970014-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0305-7372%2810%2970014-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Neo-adjuvant and adjuvant chemotherapy of gastric cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0305-7372%2810%2970014-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoradiotherapy as adjuvant treatment of gastric cancer.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0305-7372%2810%2970014-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0305-7372%2810%2970014-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0305-7372%2810%2970014-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0305-7372%2810%2970014-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

EGFR antagonists in cancer treatment

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0305-7372%2810%2970014-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of HER2 in cancer therapy and targeted drug delivery

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0305-7372%2810%2970014-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Her-2/neu and breast cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0305-7372%2810%2970014-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative study on overexpression of HER2/neu and HER3 in gastric cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0305-7372%2810%2970014-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinicopathological significance of c-erbB-2 protein expression in human gastric carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0305-7372%2810%2970014-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Double immunostaining for c-erbB-2 and p53 in human stomach cancer cells

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0305-7372%2810%2970014-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0305-7372%2810%2970014-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship of C-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0305-7372%2810%2970014-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0305-7372%2810%2970014-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0305-7372%2810%2970014-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic review of HER2 breast cancer testing

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0305-7372%2810%2970014-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0305-7372%2810%2970014-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0305-7372%2810%2970014-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Lapatinib plus capecitabine for HER2-positive advanced breast cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0305-7372%2810%2970014-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0305-7372%2810%2970014-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Lapatinib, a dual EGFR and HER2 kinase inhibitor, selectively inhibits HER2-amplified human gastric cancer cells and is synergistic with trastuzumab in vitro and in vivo.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0305-7372%2810%2970014-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0305-7372(10)70014-1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21129604

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21129604%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 January 2020

PubMed publication ID

21129604

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21129604

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21129604%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 January 2020

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37815604&oldid=1415984546"